Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinomaDaniela Sia, Josep M. Llovet, Josep Fuster et al.|Nature Communications|2015Cited by 302
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinomaRobert Montal, Josep M. Llovet, Daniela Sia et al.|Journal of Hepatology|2020Cited by 301
MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517aSara Toffanin, Josep M. Llovet, Yujin Hoshida et al.|Gastroenterology|2011Cited by 233
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivoPippa Newell, Josep M. Llovet, Sara Toffanin et al.|Journal of Hepatology|2009Cited by 222
Gene-expression signature of vascular invasion in hepatocellular carcinomaBeatriz Mínguez, Josep M. Llovet, Yujin Hoshida et al.|Journal of Hepatology|2011Cited by 170